Gene expression of forkhead transcription factors in the normal and diseased human prostate

BJU International

Volumn 103, Issue 11, 2009, Pages 1574-1580

  Van Der Heul Nieuwenhuijsen, Leonie ^a   Dits, Natasja F ^a   Jenster, Guido ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Benign prostate hyperplasia; Forkhead transcription factors; FOXD1; FOXF1; FOXF2; Prostate cancer

Indexed keywords

ANDROGEN; FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR A1; FORKHEAD TRANSCRIPTION FACTOR C1; FORKHEAD TRANSCRIPTION FACTOR D1; FORKHEAD TRANSCRIPTION FACTOR D2; FORKHEAD TRANSCRIPTION FACTOR F1; FORKHEAD TRANSCRIPTION FACTOR F2; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EPITHELIUM; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; TUMOR XENOGRAFT;

AGED; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 65549097668     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08351.x     Document Type: Article

References (29)

1. Weigel D, Jackle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors? Cell 1990 63 : 455 6 (Pubitemid 20374090)
2. Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993 364 : 412 20 (Pubitemid 23263212)
3. Katoh M, Katoh M. Human Fox gene family. Int J Oncol 2004 25 : 1495 500
4. Accili D, Arden KC. FOXOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004 117 : 421 6 (Pubitemid 38610228)
5. Coffer P, Burgering B. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004 4 : 889 98 (Pubitemid 39490764)
6. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. FOXs in development and disease. Trends Genet 2003 19 : 339 44
7. Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of FOXa1 and FOXa2 in mouse embryos and adult tissues. Gene Expr Patterns 2004 5 : 193 208 (Pubitemid 39618928)
8. Gao N, Ishii K, Mirosevich J et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 2005 132 : 3431 4 (Pubitemid 41246118)
9. Mirosevich J, Gao N, Gupta A, Shappell S, Jove R, Matusik R. Expression and role of FOXa proteins in prostate cancer. Prostate 2006 66 : 1013 28 (Pubitemid 43939204)
10. Kalin TV, Wang IC, Ackerson TJ et al. Increased levels of the FOXM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006 66 : 1712 20 (Pubitemid 43259956)
11. Jenster G. The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 1999 26 : 407 21 (Pubitemid 29411449)
12. Takayama K. Horie-Inoue K, Ikeda K et al. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Biochem Biophys Res Commun 2008 374 : 388 93
13. Van der Heul-Nieuwenhuijsen L, Hendriken P, van der Kwast T, Jenster G. Gene expression profiling of the human prostate zones. BJU Int 2006 98 : 886 97 (Pubitemid 44368045)
14. Hendriksen PJ, Dits NF, Kokame K et al. Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 2006 66 : 5012 20 (Pubitemid 43844921)
15. Singh D, Febbo PG, Ross K et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002 1 : 203 9 (Pubitemid 41039166)
16. Stuart RO, Wachsman W, Berry CC et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci USA 2004 101 : 615 20 (Pubitemid 38084685)
17. Lapointe J, Li C, Higgins JP et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004 101 : 811 6 (Pubitemid 38121040)
18. Varambally S, Yu J, Laxman B et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005 8 : 393 406 (Pubitemid 41579834)
19. Yu YP, Landsittel D, Jing L et al. Gene expression alterations in prostate cancer predicting tumour aggression and preceding development of malignancy. J Clin Oncol 2004 22 : 2790 9 (Pubitemid 41079896)
20. van Steenbrugge GJ, Groen M, Romijn JC, Schroder FH. Biological effects of hormonal treatment regimens on a transplantable human prostatic tumour line (PC-82). J Urol 1984 131 : 812 7 (Pubitemid 14109652)
21. van Weerden WM, de Ridder CM, Verdaasdonk CL et al. Development of seven new human prostate tumour xenograft models and their histopathological characterization. Am J Pathol 1996 149 : 1055 62 (Pubitemid 26334187)
22. van Weerden WM, Romijn JC. Use of nude mouse xenograft models in prostate cancer research. Prostate 2000 43 : 263 71 (Pubitemid 30367961)
23. Marques RB, van Weerden WM, Erkens-Schulze S et al. The human PC346 xenograft and cell line panel: a model system for prostate cancer progression. Eur Urol 2006 49 : 245 57 (Pubitemid 43197860)
24. DePrimo SE, Diehn M, Nelson JB et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 2002 14 : 3 7
25. Aitola M, Carlsson P, Mahlapuu M, Enerbäck S, Pelto-Huikko M. Forkhead transcription factor FOXF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions. Dev Dyn 2000 218 : 136 49 (Pubitemid 30249757)
26. Alvarez B, Martinez AC, Burgering BM, Carrera AC. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 2001 413 : 744 7 (Pubitemid 33009953)
27. Ormestad M, Astorga J, Landgren H et al. FOXF1 and FOXF2 control murine gut development by limiting mesenchymal Wnt signalling and promoting extracellular matrix production. Development 2006 133 : 833 43
28. Bild AH, Yao G, Chang JT et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006 439 : 353 7 (Pubitemid 43128862)
29. Thorat MA, Marchio C, Morimiya A et al. FOXA1 expression in breast cancer is associated with Luminal subtype and good prognosis. J Clin Pathol 2008 61 : 327 32